VEGFA and diabetic retinopathy: The study design included time points at 7, 28 days, and 3 months, allowing the tracking of transitions from early molecular events to morphological features of diabetic retinopathy (DR); this approach is consistent with data showing a preceding increase in HIF1α levels compared to VEGF during retinal ischemia (64).